The forecasted Business Enterprise R&D Expenditure in Scientific Research and Development in the US exhibits a consistent upward trend from $40.67 billion in 2024 to $55.2 billion by 2028. Given that the value stood at approximately $37 billion in 2023, this indicates a steady increase in investment. The year-on-year growth rates range from 9.3% to 6.7%, demonstrating strong and stable growth, with a compound annual growth rate (CAGR) over the five years projected at approximately 7%.
Future trends to watch for include technological advancements that could further boost R&D investment, potential policy changes impacting funding, and the role of emerging sectors such as AI and biotechnology driving expenditure.
